ABOUT THIS EPISODE

English
United States

TRANSCRIPT 🔗

SEARCH PAST EPISODES

Search past episodes of Longevity.Technology UNLOCKED.

OTHER EPISODES IN THIS PODCAST

In this week’s Longevity News Roundup, Phil Newman examines Oura’s IPO and sleep suit, movement context in dementia, dog gene therapy, Rentosertib biological clocks, and women's health. ŌURA filed for a $16 billion IPO on Nasdaq under ticker Oura, seeking to raise up to $3 billion. Simultaneously…
Sponsor: Sooo.me Sooo.me™ is a longevity-focused nutraceutical brand offering science-backed supplements designed to support healthy aging, energy, focus, cellular health, and overall wellbeing. Its range combines high-purity ingredients, medicinal mushroom extracts, and targeted formulations with…
What would have to be true for AI to genuinely change the trajectory of human aging? The answer is more complicated than simply discovering an “anti-aging drug.” AI is already compressing parts of drug discovery, with one AI-designed candidate reaching Phase 2 trials in under 30 months, while new …
Guests: Paola Telfer Founder and CEO of Sens.ai LinkedIn: www.linkedin.com/in/paolatelfer/ Website: sens.ai/ Eric Verdin, MD President and CEO of the Buck Institute for Research on Aging LinkedIn: www.linkedin.com/in/eric-verdin-md/ Website: www.buckinstitute.org/ ---------- What if we could tr…
In this week’s Longevity News Roundup, Phil Newman examines the developments reshaping longevity and healthspan, from a major biotech investment in hair loss to AI-driven drug repurposing, the industry’s communication challenge, biological-age testing at population scale, and the push to manufactur…
Disclaimer: The podcast and artwork embedded on this page are from Longevity.Technology, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.